Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
European Journal of Medicinal Chemistry
|
March 1, 2014
Part I. Synthesis, biological evaluation and docking studies of new 2-furylbenzimidazoles as antiangiogenic agents
Ahmed Temirak, Yasser M Shaker, Fatma A F Ragab, et al.
Archiv Der Pharmazie
|
February 12, 2020
Design, synthesis, and molecular docking of novel 2-arylbenzothiazole multiangiokinase inhibitors targeting breast cancer
Heba T Abdel-Mohsen, Eman A Abd El-Meguid, Ahmed M El Kerdawy, et al.
Journal of Basic Microbiology
|
August 14, 2019
Characterization of a new efficient low molecular weight Bacillus subtilis NRC <sub>16</sub> levansucrase and its levan
Bassem M Salama, Wafaa A Helmy, Tamer I M Ragab, et al.
European Journal of Medicinal Chemistry
|
December 4, 2018
Type IIA - Type IIB protein tyrosine kinase inhibitors hybridization as an efficient approach for potent multikinase inhibitor development: Design, synthesis, anti-proliferative activity, multikinase inhibitory activity and molecular modeling of novel indolinone-based ureides and amides
Wagdy M Eldehna, Ahmed M El Kerdawy, Ghada H Al-Ansary, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
June 14, 2018
l-Amino acid oxidase from Cerastes vipera snake venom: Isolation, characterization and biological effects on bacteria and tumor cell lines
Walaa H Salama, Nihal M Ibrahim, Amr E El Hakim, et al.
European Journal of Medicinal Chemistry
|
July 9, 2019
Novel potent substituted 4-amino-2-thiopyrimidines as dual VEGFR-2 and BRAF kinase inhibitors
Heba T Abdel-Mohsen, Mohamed A Omar, Ahmed M El Kerdawy, et al.
Archiv Der Pharmazie
|
August 9, 2017
New Coumarin Derivatives as Anti-Breast and Anti-Cervical Cancer Agents Targeting VEGFR-2 and p38α MAPK
Rasha Z Batran, Dina H Dawood, Samia A El-Seginy, et al.
Archiv Der Pharmazie
|
June 8, 2012
New pyrimidinone and fused pyrimidinone derivatives as potential anticancer chemotherapeutics
Aymn E Rashad, Ahmed H Shamroukh, Nabil M Yousif, et al.
Archiv Der Pharmazie
|
January 12, 2018
Design, synthesis, and molecular docking of novel indole scaffold-based VEGFR-2 inhibitors as targeted anticancer agents
Hanaa M Roaiah, Iman A Y Ghannam, Islam H Ali, et al.
Archiv Der Pharmazie
|
February 6, 2014
Synthesis, biological evaluation, and docking studies of new 2-furylbenzimidazoles as anti-angiogenic agents: part II
Ahmed Temirak, Yasser M Shaker, Fatma A F Ragab, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
European Journal of Medicinal Chemistry
|
March 1, 2014
Part I. Synthesis, biological evaluation and docking studies of new 2-furylbenzimidazoles as antiangiogenic agents
Ahmed Temirak, Yasser M Shaker, Fatma A F Ragab, et al.
Archiv Der Pharmazie
|
February 12, 2020
Design, synthesis, and molecular docking of novel 2-arylbenzothiazole multiangiokinase inhibitors targeting breast cancer
Heba T Abdel-Mohsen, Eman A Abd El-Meguid, Ahmed M El Kerdawy, et al.
Journal of Basic Microbiology
|
August 14, 2019
Characterization of a new efficient low molecular weight Bacillus subtilis NRC <sub>16</sub> levansucrase and its levan
Bassem M Salama, Wafaa A Helmy, Tamer I M Ragab, et al.
European Journal of Medicinal Chemistry
|
December 4, 2018
Type IIA - Type IIB protein tyrosine kinase inhibitors hybridization as an efficient approach for potent multikinase inhibitor development: Design, synthesis, anti-proliferative activity, multikinase inhibitory activity and molecular modeling of novel indolinone-based ureides and amides
Wagdy M Eldehna, Ahmed M El Kerdawy, Ghada H Al-Ansary, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
June 14, 2018
l-Amino acid oxidase from Cerastes vipera snake venom: Isolation, characterization and biological effects on bacteria and tumor cell lines
Walaa H Salama, Nihal M Ibrahim, Amr E El Hakim, et al.
European Journal of Medicinal Chemistry
|
July 9, 2019
Novel potent substituted 4-amino-2-thiopyrimidines as dual VEGFR-2 and BRAF kinase inhibitors
Heba T Abdel-Mohsen, Mohamed A Omar, Ahmed M El Kerdawy, et al.
Archiv Der Pharmazie
|
August 9, 2017
New Coumarin Derivatives as Anti-Breast and Anti-Cervical Cancer Agents Targeting VEGFR-2 and p38α MAPK
Rasha Z Batran, Dina H Dawood, Samia A El-Seginy, et al.
Archiv Der Pharmazie
|
June 8, 2012
New pyrimidinone and fused pyrimidinone derivatives as potential anticancer chemotherapeutics
Aymn E Rashad, Ahmed H Shamroukh, Nabil M Yousif, et al.
Archiv Der Pharmazie
|
January 12, 2018
Design, synthesis, and molecular docking of novel indole scaffold-based VEGFR-2 inhibitors as targeted anticancer agents
Hanaa M Roaiah, Iman A Y Ghannam, Islam H Ali, et al.
Archiv Der Pharmazie
|
February 6, 2014
Synthesis, biological evaluation, and docking studies of new 2-furylbenzimidazoles as anti-angiogenic agents: part II
Ahmed Temirak, Yasser M Shaker, Fatma A F Ragab, et al.
Page
of 6